ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Allakos Inc

Allakos Inc (ALLK)

0.9688
-0.0104
(-1.06%)
Cerrado 12 Enero 3:00PM
0.9852
0.0164
(1.69%)
Fuera de horario: 6:54PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.9852
Postura de Compra
0.90
Postura de Venta
2.30
Volume Operado de la Acción
149,571
0.94 Rango del Día 0.9796
0.535 Rango de 52 semanas 3.36
Capitalización de Mercado [m]
Precio Anterior
0.9792
Precio de Apertura
0.9603
Última hora de negociación
Volumen financiero
US$ 143,396
Precio Promedio Ponderado
0.958713
Volumen promedio (3 m)
738,495
Acciones en circulación
89,343,634
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.47
Beneficio por acción (BPA)
-2.08
turnover
-
Beneficio neto
-185.7M

Acerca de Allakos Inc

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig... Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Allakos Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALLK. The last closing price for Allakos was US$0.98. Over the last year, Allakos shares have traded in a share price range of US$ 0.535 to US$ 3.36.

Allakos currently has 89,343,634 shares in issue. The market capitalisation of Allakos is US$87.49 million. Allakos has a price to earnings ratio (PE ratio) of -0.47.

ALLK Últimas noticias

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm PR Newswire NEW YORK, Dec. 19, 2024 NEW YORK, Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.2648-21.1841.251.25010.93067243641.08474127CS
4-0.0848-7.925233644861.071.380.93064428551.16168938CS
120.332851.01164929490.65241.5550.64367384951.19012192CS
260.165220.14634146340.821.5550.5355177971.01322CS
52-2.2548-69.59259259263.243.360.5357764151.15694483CS
156-7.3948-88.24343675428.388.730.53510850054.02504202CS
260-87.3148-98.884258210688.3157.980.53593741715.13990935CS

ALLK - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Allakos?
El precio actual de las acciones de Allakos es US$ 0.9852
¿Cuántas acciones de Allakos están en circulación?
Allakos tiene 89,343,634 acciones en circulación
¿Cuál es la capitalización de mercado de Allakos?
La capitalización de mercado de Allakos es USD 87.49M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Allakos?
Allakos ha negociado en un rango de US$ 0.535 a US$ 3.36 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Allakos?
El ratio precio/beneficio de Allakos es -0.47
¿Cuál es la moneda de reporte de Allakos?
Allakos presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Allakos?
El último beneficio anual de Allakos es USD -185.7M
¿Cuál es la dirección registrada de Allakos?
La dirección registrada de Allakos es 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Allakos?
La dirección del sitio web de Allakos es www.allakos.com
¿En qué sector industrial opera Allakos?
Allakos opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

ALLK Discussion

Ver más
glenn1919 glenn1919 3 meses hace
ALLK.................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 3 meses hace
nice set up
👍️0
Banjo50 Banjo50 3 meses hace
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
Monksdream Monksdream 10 meses hace
ALLK 10Q due 3/19
👍️0
Monksdream Monksdream 10 meses hace
ALLK under $2
👍️0
Monksdream Monksdream 10 meses hace
ALLK 10Q due March 12
👍️0
Monksdream Monksdream 10 meses hace
ALLK 10Q due March 5
👍️0
glenn1919 glenn1919 10 meses hace
ALLK..........................................................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 meses hace
ALLK under $2
👍️0
RobH1312 RobH1312 3 años hace
THIS POS IS A SCAM GONNA GO DOWN DOWN DOWN!!!

















imo
👍️0
REAGAN REAGAN 3 años hace
We will go short on this one.
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Agree, the next couple weeks should be very interesting .
👍️0
REAGAN REAGAN 3 años hace
The whole Nasdaq is crashing. A stock whose IP doesn’t work should be pulverized next week.
👍️0
REAGAN REAGAN 3 años hace
Made it go down 95%. The technology doesn’t work….
👍️0
FROZENFLAME FROZENFLAME 3 años hace
It was a good flip, still looks attractive at this level, but I will wait .
👍️0
REAGAN REAGAN 3 años hace
This aged well
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today reported data from ENIGMA 2, a 24-week Phase 3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy confirmed eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and KRYPTOS, a 24-week Phase 2/3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy-confirmed eosinophilic esophagitis (EoE). Both ENIGMA 2 and KRYPTOS studies met their histologic co-primary endpoints, but did not achieve statistical significance on the patient reported symptomatic co-primary endpoints.
“We are deeply disappointed that the studies did not achieve their symptomatic endpoints,” said Robert Alexander, PhD, Chief Executive Officer of Allakos. “The company is grateful to the patients with eosinophilic gastrointestinal diseases (EGIDs) and to the investigators who participated in the ENIGMA and KRYPTOS trials.”
👍️0
REAGAN REAGAN 3 años hace
Zero squeeeze. What’s up with this company. How’d it lose 97% of value in one year?
👍️0
REAGAN REAGAN 3 años hace
So what’s the deal with this stock? Why has the stock price fallen 97%? Where do you see the company has $500m cash on hand?
👍️0
BullofLA BullofLA 3 años hace
Yup, total scam, run away.
👍️0
Inves2day Inves2day 3 años hace
Allakos holders - please read and share the link below.


Stock wash sale 30 days period ended on 21 January 2022. December sellers will be looking to buy back now. Two after hours buys yesterday make more sense now.

ALLK is a forgotten share, but not for those who have to buy it back. The seller is gone for two days, but the sentiment is negative around all Nasdaq shares hence negative ends on Thu and Fr. This will change too.
I saw on Thursday 20 January that there was an appetite to climb up, really. Virtually no seller around. During the day all was going well, MMs were ticking it nicely higher until that moment of crash caused by Netflix followed by the entire Nasdaq falling down. Friday Nasdaq still down so ALLK too. But every crash ends and reversal starts for new buyers.

Look, as ALLK holders, we all can and have to create a need for shorters and those who sold in December for tax reasons to start the buy back. We need an bigger action to close day at 5-10% up to get noticed in media.
I. e. ADGI reversed exactly after 30 days wash sale. Allakos can do the same if we really want it.

Sell only if you really have to or Hold it for a few more days to see if recovery kicks in with Nasdaq stabilising.

Allakos Inc at $7 mcap is slightly lower than cash and equivalents.
We know they did not deliver but ffs share is down from $84 to $7 and they still be looking to use thst drug in another areas.

Please share the below post on Twitter for awareness.

https://twitter.com/inves2day/status/1485023226753437698?t=aK2TQngCviUwopFKMOEmjQ&s=19


Thank you for reading and sharing.

*23 Jan - my account on StockTwits has been suspended after posting the above link*
👍️0
Banjo50 Banjo50 3 años hace
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
donwillems donwillems 3 años hace
well this has 3 stages for me, everything +9.50, allright
everything above 10+, superb
everything above 12.50, winner winner chicken dinner.

A company with 500 million up their sleeves, I think they might figure something out.

And whats more, why did I buy into this company?
I have EOE myself, it's being triggered by cow milk with me and my throat and stumach gets hurt really bad by the eosiphiniles If I don't watch out with avoiding everything with milk.

I'm totally wondered here how that however the drug significantly reducing the eosiphiniles in situ doesn't get a response on the symptons, this starts me wondering if the direct symptons only thrive by the (food)allergy people have with it.

For now, I avoid milk and use omeprazole to completly suppres the effects, corticosteriod can be used locally but they are bad for blood vessels long term.

To get to the point, I think this drug isn't wrote off at all, the eosiphiniles do damage the throat a lot long term in this disease, if left untreathed, the throat will start forming circular scars, making it smaller and making it long term impossible to get food into the stumach.

The research completly ignores this problem, while it's the second main cause for treating this disease, unimaginable if you ask me.
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Sure she’s trying to breakout !
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Squeeze !
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Dip and rip, short trying so hard !!
👍️0
da_stock_analyst da_stock_analyst 3 años hace
Two Stocks to Watch: #NXTD ?? #ALLK ?? Should you buy now for the possible run-up? Technical analysis!
👍️0
Huti Huti 3 años hace
20??? Maybe??? What do you guys think?
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
DD here Can someone Box/Sticky it
https://twitter.com/tryingBot05/status/1473861479309152257
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
https://twitter.com/SilentTrader93/status/1474112595133177859
https://twitter.com/RealTimeTradez/status/1473809286354583557
https://twitter.com/RealTimeTradez/status/1474081174448398343
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
ALLK New Patient Dec.21 2021
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
https://twitter.com/SilentTrader93/status/1474112595133177859/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
https://twitter.com/RealTimeTradez/status/1473809286354583557/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
https://twitter.com/RealTimeTradez/status/1474081174448398343/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
https://twitter.com/tryingBot05/status/1473861479309152257/photo/1
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Next week should be sooo good IMO .
👍️0
Laszlo1 Laszlo1 3 años hace
Took a starter
👍️0
forgiveness7x7 forgiveness7x7 3 años hace
that's what i'm here scouting out. looks like analysts have different opinions on price. from 10.00 to 60.00
i think it is a short attack and whatever else
👍️0
Laszlo1 Laszlo1 3 años hace
What happened here what causes the huge drop?
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Huge volume over 63M $$$
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Agree, a little bit more Consolidations, before the next leg up, then BOOOOM .
👍️0
alchemytrader alchemytrader 3 años hace
10.79
👍️0
Justfactsmam Justfactsmam 3 años hace
looks like the Short Squeeze commencing!
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Very small SS short squeeze will take it to the moon .
👍️0
FROZENFLAME FROZENFLAME 3 años hace
I’m good with $50 lol .
👍️0
sirglenn sirglenn 3 años hace
Maybe they'll buy their own stock. LOL.
👍️0
Justfactsmam Justfactsmam 3 años hace
And GOLDMAN lowered the price target to $60.00...(6X) from here. Some see things others don't.
👍️0
crudeoil24 crudeoil24 3 años hace
9.91 > Morgan Stanley Maintains Equal-Weight on Allakos, Lowers Price Target to $10
All these analysts are comedians!
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Expecting $15-$20 next week .
👍️0
FROZENFLAME FROZENFLAME 3 años hace
Over $10 premarket .
👍️0
maximumgriff maximumgriff 3 años hace
It’s never too late :)
👍️0

Su Consulta Reciente

Delayed Upgrade Clock